BSE filing, NSE: WEPSOLN. Summary written from the filing by ALFA Finder's alert engine.
WEP Solutions Ltd: key numbers
- Share price
- ₹30.90
- Market cap
- ₹113.7 Cr
- Revenue (annual)
- ₹67.91 Cr
- Net profit (annual)
- ₹2.06 Cr
- P/E (TTM)
- 61.2×Sector 45.3×
- Promoter holding
- 41.04%-0.14% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from WEP Solutions Ltd
All →WEP Solutions Board Meeting Date
WeP Solutions intimated a board meeting scheduled for 13 November 2026. It will consider the un-audited results for the quarter and half-year ended 30 September 2026.
WEP Solutions Management Change
WEP Solutions disclosed the tenure completion of Independent Director Grama Hiriyannaiah Visweswara effective 19 September 2026. No replacement appointment was announced in this filing.
WEP Solutions Annual General Meeting
WeP Solutions held its 31st AGM on 16 September 2026, transacting all agenda resolutions. A final dividend of Rs.0.50 per share and the ESOP Plan 2026 were approved.
WEP Solutions Annual Report
WeP Solutions Limited submitted its Annual Report for FY 2025-26 and the notice for its 31st Annual General Meeting. The meeting is scheduled for September 16, 2026.
WEP Solutions Annual General Meeting
Wep Solutions Limited has scheduled its 31st Annual General Meeting for September 16, 2026. The book closure period is set from September 10 to September 16, 2026.
WEP Solutions Management Change
WeP Solutions Limited appointed Mr. C. Muniramaiah as the new CFO and re-assigned Mr. Pradeep S to the position of Chief Financial Advisor.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.